Detalhe da pesquisa
1.
Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry.
BJU Int
; 125(6): 853-860, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971335
2.
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
Eur Urol
; 81(4): 407-413, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123819
3.
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study.
Prostate Cancer Prostatic Dis
; 24(2): 567-574, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504940
4.
Identification of new genetic risk factors for prostate cancer.
Asian J Androl
; 11(1): 49-55, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19050691
5.
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
Eur Urol
; 74(4): 422-429, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29960750
6.
Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.
Eur Urol
; 70(4): 668-674, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26951947
7.
Support for recent graduates.
Vet Rec
; 178(25): 639, 2016 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27313257
8.
Multiple loci on 8q24 associated with prostate cancer susceptibility.
Nat Genet
; 41(10): 1058-60, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19767752
9.
Multiple newly identified loci associated with prostate cancer susceptibility.
Nat Genet
; 40(3): 316-21, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18264097
10.